IRIS

Multicenter phase III study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria / Brodsky, Ra; Young, Ns; Antonioli, E; Risitano, ANTONIO MARIA; Schrezenmeier, H; Schubert, J; Valls, Ag; Coyle, L; de Castro, C; Fu, Cl; Maciejewski, Jp; Bessler, M; Kroon, Ha; Rother, Rp; Hillmen, P.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 111:(2008), pp. 1840-1847.

Multicenter phase III study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

RISITANO, ANTONIO MARIA;
2008
2008
BLOOD
Multicenter phase III study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria / Brodsky, Ra; Young, Ns; Antonioli, E; Risitano, ANTONIO MARIA; Schrezenmeier, H; Schubert, J; Valls, Ag; Coyle, L; de Castro, C; Fu, Cl; Maciejewski, Jp; Bessler, M; Kroon, Ha; Rother, Rp; Hillmen, P.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 111:(2008), pp. 1840-1847.
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/569353
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact